Jasper Therapeutics, Inc. (JSPR) stock

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$14.76+0.01 (+0.07%)

Close on Nov 11, 2026Market cap $491.13MP/E –Yield –

Jasper Therapeutics statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q3 FY2026, expected soon
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $491.13M; $289.51M
Enterprise Value: $483.82M; $155.84M
PB Ratio: 347.58; 2.13
P/TBV Ratio: 347.58; 2.38

Share statisticsIndustry

Shares Outstanding: 33M; 58M
Shares Change (YoY): 70.2%; 10.9%
Shares Change (QoQ): 0.30%; 0.48%
Float: 22M; 49M
Shares Held by Insiders: 33.0%; 12.1%
Shares Held by Institutions: 36.1%; 56.4%

Short sellingIndustry

Short Interest: 7M; –
Short Interest Change: 6.15%; -0.80%
Short % of Float: 30.8%; 9.06%
Short % of Shares Outstanding: 20.7%; 6.30%
Days to Cover: 16.99; 5.15

Stock price statisticsIndustry

52-Week High: $72.60; –
52-Week Low: $0.34; –
20-Day Moving Average: $13.81; –
50-Day Moving Average: $10.87; –
200-Day Moving Average: $16.30; –
Average True Range (14): $4.37; –
Price Change (1 Week): -3.75%; -0.58%
Price Change (1 Month): 2878.2%; -0.28%
Price Change (3 Months): 1610.1%; -17.1%
Price Change (6 Months): -46.5%; -20.1%
Price Change (YTD): -73.1%; -20.1%
Price Change (1 Year): -72.4%; -19.3%
Price Change (3 Years): -92.5%; -22.2%
Price Change (5 Years): -99.4%; -76.4%
Average Volume (10 Days): 32,850; –
Average Volume (20 Days): 60,843; –
Average Volume (90 Days): 822,326; –
Relative Volume: 0.08; 0.73
Relative Strength Index (14): 51.7; 47.7
Volatility (1 Year): 16082.8%; 80.2%

Returns on capitalIndustry

Return on Equity (ROE): -255.0%; -51.3%
Return on Assets (ROA): -109.1%; -40.7%
Return on Capital Employed (ROCE): -1394.1%; -38.1%

Financial positionIndustry

Current Ratio: 1.47; 3.30
Quick Ratio: 0.93; 2.40

EfficiencyIndustry

Profits Per Employee: -$1.44M; -$683.67K
Employee Count: 22; 75

Income statement (TTM)Industry

Operating Income: -$55.16M; -$20.99M
Net Income: -$31.77M; -$21.61M
EBITDA: -$54.60M; -$16.85M
EPS (Diluted): -$1.59; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $7.31M; $66.80M
Net Cash (Debt): $7.31M; $16.56M
Net Cash Per Share: $0.22; $0.71
Equity (Book Value): $1.41M; $52.23M
Book Value Per Share: $0.04; $1.50
Tangible Book Value: $1.41M; $26.10M
Working Capital: $3.73M; $78.41M

Cash flow (TTM)Industry

Operating Cash Flow: -$60.33M; -$12.27M

Dividends and yieldsIndustry

Earnings Yield: -6.47%; -20.1%

Scores and fair valueIndustry

Altman Z-Score: -24.71; 0.31
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	JSPR	S&P 500	Difference	JSPR per year	S&P 500 per year
1 month	-13.7%	-2.4%	−11.3 pts
3 months	+1552.7%	-1.2%	+1553.8 pts
Year to date	-73.1%	+12.3%	−85.4 pts
1 year	-71.1%	+12.4%	−83.5 pts
3 years	-92.9%	+78.8%	−171.7 pts	-58.5%	+21.4%
5 years	-99.4%	+75.2%	−174.6 pts	-64.2%	+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

7M JSPR shares were sold short on Oct 30, 2026, up 6.1% from the previous report, or 30.82% of the shares available to trade. At recent volumes it would take 17.0 days to buy them back. Over the last 20 sessions, 48.2% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	6,872,402	+6.1%	404,446	17.0
Oct 15, 2026	6,474,345	+4.1%	349,391	18.5
Sep 30, 2026	6,218,239	+7.1%	381,578	16.3
Sep 15, 2026	5,808,274	+5.8%	353,411	16.4
Aug 31, 2026	5,492,117	+2.5%	714,460	7.7
Aug 14, 2026	5,358,334	+24.3%	690,501	7.8
Jul 31, 2026	4,311,877	+159.5%	4,576,589	1.0
Jul 15, 2026	1,661,803	-2.4%	882,127	1.9
Jun 30, 2026	1,703,161	-13.0%	623,080	2.7
Jun 15, 2026	1,958,290	-12.8%	957,316	2.0
May 29, 2026	2,246,874	-9.7%	236,234	9.5
May 15, 2026	2,487,193	-8.5%	242,615	10.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?